Debio0932, a second-generation oral heat shock protein (HSP) inhibitor, in patients with advanced cancer—results of a first-in-man dose-escalation study with a fixed-dose extension phase
Year: 2015
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
Authors: N. Isambert, J.-P. Delord, J.-C. Soria, A. Hollebecque, C. Gomez-Roca, D. Purcea, E. Rouits, R. Belli, P. Fumoleau
Language: English
Topic: Heat shock proteins research
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2126578811
